BNP Paribas Asset Management
MDCO

BNP Paribas Asset Management’s Medicines Co MDCO Stock Holding History

BNP Paribas Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-277,792
Closed -$13.9M – 869
2019
Q3 		$13.9M Sell
277,792
-106,850
-28% -$4.26M 0.11% 245
2019
Q2 		$14M Buy
+384,642
New +$12.6M 0.11% 234
2017
Q1 		– Sell
-67,544
Closed -$2.29M – 997
2016
Q4 		$2.29M Sell
67,544
-176,493
-72% -$6.26M 0.02% 625
2016
Q3 		$9.21M Buy
244,037
+42,947
+21% +$1.62M 0.08% 338
2016
Q2 		$6.76M Sell
201,090
-176,862
-47% -$6.24M 0.06% 415
2016
Q1 		$12M Sell
377,952
-55,745
-13% -$1.82M 0.1% 269
2015
Q4 		$16.2M Buy
433,697
+23,094
+6% +$873K 0.14% 200
2015
Q3 		$15.6M Buy
410,603
+124,868
+44% +$4.38M 0.14% 221
2015
Q2 		$8.18M Buy
285,735
+96,730
+51% +$2.69M 0.07% 377
2015
Q1 		$5.3M Buy
+189,005
New +$5.31M 0.04% 464

Other funds holding MDCO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

BNP Paribas Asset Management's MDCO Position: Q4 2019 in Review

BNP Paribas Asset Management sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 277,792 shares — an estimated $13.9M sold.

BNP Paribas Asset Management first reported a position in MDCO in Q1 2015 and held it in 10 quarters. The position peaked at $16.2M in Q4 2015. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • BNP Paribas Asset Management reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • BNP Paribas Asset Management sold 277,792 Medicines Co shares in Q4 2019, an estimated $13.9M.
  • BNP Paribas Asset Management first reported a position in Medicines Co in Q1 2015 and held it in 10 quarters.
  • BNP Paribas Asset Management's Medicines Co position peaked at $16.2M in Q4 2015.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on BNP Paribas Asset Management's 13F filing for Q4 2019, filed 11 Feb 2020.